← Back to Clinical Trials
Recruiting NCT07589673

NCT07589673 Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07589673
Status Recruiting
Phase
Sponsor Chungnam National University
Condition Chronic Disease
Study Type INTERVENTIONAL
Enrollment 288 participants
Start Date 2026-05-10
Primary Completion 2026-07-10

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Online Shared Decision-Making Educational Program for NursesOnline Shared Decision-Making Educational Program for Patients With Chronic DiseasesGeneral Communication Education for Nurses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 288 participants in total. It began in 2026-05-10 with a primary completion date of 2026-07-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases. Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences. The study includes an evaluation phase. In the evaluation phase, the program will be tested among nurses working in general hospitals and adults with chronic diseases living in the community. Outcomes related to shared decision-making will be assessed at baseline, immediately after the 4-week program, and 1 month later. The study is expected to improve shared decision-making competence, experience, and preparedness among both nurses and patients.

Eligibility Criteria

Inclusion Criteria for Nurse: * Registered nurses currently providing direct patient care in participating general hospitals * Able to understand the purpose and procedures of the study and provide informed consent * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Nurse: * Not currently engaged in direct patient care * Unable to clearly express willingness to participate * Unable to complete the educational program or questionnaires because of technical or language limitations Inclusion Criteria for Patients: * Adults aged 19 years or older living in the community * Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease, with at least 3 months elapsed since diagnosis * Able to understand the purpose and procedures of the study and provide informed consent * Able to read and respond to survey questions * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Patients: * Cognitive impairment or communication problems that make participation difficult * Unable to complete the educational program or questionnaires because of technical or language limitations

Contact & Investigator

Central Contact

Geunyoung Lee

✉ lgy2513@gmail.com

📞 +82 42-580-8407

Frequently Asked Questions

Who can join the NCT07589673 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07589673 currently recruiting?

Yes, NCT07589673 is actively recruiting participants. Contact the research team at lgy2513@gmail.com for enrollment information.

Where is the NCT07589673 trial being conducted?

This trial is being conducted at Daejeon, South Korea.

Who is sponsoring the NCT07589673 clinical trial?

NCT07589673 is sponsored by Chungnam National University. The trial plans to enroll 288 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology